JAGSNPHARM Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > jagsnpharm

Technical Analysis

Technical Strength: 5.9 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 53.6. According to RSI analysis, jagsnpharm is technically strong. 9.0 JAGSNPHARM RSI Chart
MACD (?) MACD: 0.638 and Signal Line: 0.737. According to MACD analysis, a bearish crossover just happend and it's a negative signal. 0.0 JAGSNPHARM MACD Chart
Simple Moving Average (?) According to simple moving average analysis, jagsnpharm is in a uptrend. Support level is at 26.1. 9.0 JAGSNPHARM Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, jagsnpharm is in a uptrend. Support level is at 26.3. 9.0 JAGSNPHARM Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.562. 5.0 JAGSNPHARM Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 26.467 and 25.7. Resistance level is 28.95. 6.5 JAGSNPHARM Fibonacci Retracement Chart
Average True Range (?) ATR: 1.85 NA JAGSNPHARM Average True Range Chart
Average Directional Index (?) ADX is 38.3 which means JAGSNPHARM is in a trend. NA JAGSNPHARM Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
November 15, 2019
Open Price 26.2
High Price 28.8
Low Price 26.1
Close Price 26.55
Absolute Change 0.65
Percentage Change 2.51%
Weekly Change -3.98%
Monthly Change 14.9%
Yearly Change -7.17%
52-week high 32.7
52-week low 20.2
Corporate Actions
ExDate Purpose
September 20, 2019 AGM/DIV-RS 0.25 PER SH
September 18, 2018 AGM/DIV-RE 0.10 PER SH
September 21, 2016 AGM/DIV-RE 0.10 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.914
Confidence in Beta2.21%
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 15 November 2019: Deliverable Quantity:5.27e+03 NA JAGSNPHARM Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 15 November 2019: Daily Volatility:0.5483 NA JAGSNPHARM Annualized Daily Volatility (Spot Price) Chart


April 26, 2018 Updates Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Dear Sir/Madam,
April 11, 2018 Disc. under Reg.30 of SEBI (SAST) Reg.2011 Jagsonpal Pharmaceuticals Limited has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
See all Announcements

Board Meetings

Date Meeting Date Purpose
November 06, 2019 November 14, 2019 Financial Results To consider and approve the financial results for the period ended September 30, 2019
August 02, 2019 August 13, 2019 Financial Results To consider and approve the financial results for the period ended Jun 30, 2019
See all Board Meetings

Get Clearnifty's Android App.

Get clearnifty on Google Play
Get clearnifty on Google Play